Showing results (1-10 of 510) with videos related to

Sort By:
Pageof 51
Haematologica|January 22, 2002
The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patientsUgo De Giorgi, Giovanni Rosti, Giorgio Papiani, et al.
Cancer Control : Journal of the Moffitt Cancer Center|February 25, 2003
High-dose chemotherapy in adult patients with germ cell tumorsUgo De Giorgi, Giorgio Papiani, Giuseppe Severini, et al.
Tumori|July 27, 2011
Expectations of survivors, caregivers and healthcare providers for testicular cancer survivorship and quality of lifeSilvia De Padova, Giovanni Rosti, Emanuela Scarpi, et al.
Urologic Oncology|June 27, 2009
Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic featuresUgo De Giorgi, Giovanni Rosti, Roberto Salvioni, et al.
American Journal of Clinical Oncology|December 15, 2004
Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experienceUgo De Giorgi, Giovanni Rosti, Giorgio Papiani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?Giuseppe Luigi Banna, Ugo De Giorgi, Benvenuto Ferrari, et al.
Critical Reviews in Oncology/Hematology|June 7, 2003
Prevention and therapy of neutropenia in elderly patientsGiovanni Rosti, Barbara Kopf, Anna Cariello, et al.
Cancer|July 19, 2002
Salvage high-dose chemotherapy in patients with germ cell tumors: an Italian experience with 84 patientsGiovanni Rosti, Ugo De Giorgi, Roberto Salvioni, et al.
The International Journal of Biological Markers|May 19, 2015
Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 functionUgo De Giorgi, Juping Yuan, Mauro Moroni, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2006
Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancerUgo De Giorgi, Massimo Giannini, Luca Frassineti, et al.
Pageof 51